BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 20736855)

  • 21. Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.
    Zeliadt SB; Sekaran NK; Hu EY; Slatore CC; Au DH; Backhus L; Wu DY; Crawford J; Lyman GH; Dale DC
    J Thorac Oncol; 2011 Oct; 6(10):1726-32. PubMed ID: 21857253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.
    Enatsu S; Yoshida J; Yokose T; Nishimura M; Nishiwaki Y; Shirakusa T; Nagai K
    Ann Thorac Surg; 2006 Jan; 81(1):298-304. PubMed ID: 16368385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage II.
    Toffalorio F; Radice D; Spaggiari L; Sinno V; Barberis M; Spitaleri G; Giovannini M; Delmonte A; Catania C; Noberasco C; Brambilla D; de Braud F; Veronesi G; Solli P; De Pas T
    J Thorac Oncol; 2012 Jul; 7(7):1124-30. PubMed ID: 22610258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
    Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
    Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.
    Kogure Y; Ando M; Saka H; Chiba Y; Yamamoto N; Asami K; Hirashima T; Seto T; Nagase S; Otsuka K; Yanagihara K; Takeda K; Okamoto I; Aoki T; Takayama K; Yamasaki M; Kudoh S; Katakami N; Miyazaki M; Nakagawa K
    J Thorac Oncol; 2013 Jun; 8(6):753-8. PubMed ID: 23575412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non-small Cell Lung Cancer.
    Hanagiri T; Sugio K; Mizukami M; Ichiki Y; Sugaya M; Yasuda M; Takenoyama M; Yasumoto K
    J Thorac Oncol; 2008 Oct; 3(10):1127-32. PubMed ID: 18827608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.
    Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Shimokata K; Inoue H; Nukiwa T; Miyaoka E;
    J Thorac Oncol; 2008 Jan; 3(1):46-52. PubMed ID: 18166840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer.
    Fernando HC; Santos RS; Benfield JR; Grannis FW; Keenan RJ; Luketich JD; Close JM; Landreneau RJ
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):261-7. PubMed ID: 15678034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.
    Cerfolio RJ; Bryant AS; Scott E; Sharma M; Robert F; Spencer SA; Garver RI
    Chest; 2006 Dec; 130(6):1796-802. PubMed ID: 17166999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
    Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
    J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
    Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
    Rades D; Setter C; Dahl O; Schild SE; Noack F
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
    Osarogiagbon RU; Yu X
    J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy?
    Asamura H; Nakayama H; Kondo H; Tsuchiya R; Shimosato Y; Naruke T
    J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1125-34. PubMed ID: 8642812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung cancer in women, a different disease: survival differences by sex in Turkey.
    Ulas A; Tokluoglu S; Kos M; Silay K; Akinci S; Oksuzoglu B; Alkis N
    Asian Pac J Cancer Prev; 2015; 16(2):815-22. PubMed ID: 25684531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender difference in survival of resected non-small cell lung cancer: histology-related phenomenon?
    Chang JW; Asamura H; Kawachi R; Watanabe S
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):807-12. PubMed ID: 19327500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?
    Ruffini E; Asioli S; Filosso PL; Buffoni L; Bruna MC; Mossetti C; Solidoro P; Oliaro A
    J Thorac Oncol; 2011 Feb; 6(2):319-26. PubMed ID: 21164365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrence and survival after surgical treatment of lung cancer].
    Hjelde H; Sundstrøm S; Ødegård A; Hatlinghus S; Abusland AB; Haaverstad R
    Tidsskr Nor Laegeforen; 2010 Jan; 130(1):25-8. PubMed ID: 20094119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.